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Abstract: The development of new approaches to obtain optically pure β-hydroxy esters is 
an important area in synthetic organic chemistry since they are precursors of other high 
value compounds. Herein, the kinetic resolution of racemic β-hydroxy esters using a 
planar-chiral DMAP derivative catalyst is presented. Following this procedure, a range of 
aromatic β-hydroxy esters was obtained in excellent selectivities (up to s = 107) and high 
enantiomeric excess (up to 99% ee). Furthermore, the utility of the present method was 
demonstrated in the synthesis of (S)-3-hydroxy-N-methyl-3-phenylpropanamide, a key 
intermediate for bioactive molecules such as fluoxetine, tomoxetine or nisoxetine, in its 
enantiomerically pure form. 
Keywords: non-enzymatic kinetic resolution; β-hydroxy esters; planar-chiral DMAP 
catalyst; ferrocenyl catalyst 
 
1. Introduction 
In the recent decades, the development of methods for asymmetric synthesis of organic molecules 
has gained increasing importance [1]. As a representative example, the development of approaches to 
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achieve optically pure β-hydroxy esters has emerged as an important issue in synthetic organic 
chemistry [2], since these chiral derivatives have received special attention due to their importance as 
intermediates in the synthesis of a variety of important chemicals, such as β-lactams, pheromones and 
carotenoids [3,4]. In addition, β-hydroxy esters are also precursors to norepinephrine or serotonin 
reuptake inhibitors that are an important class of drugs. For example, fluoxetine (Prozac), which is 
formulated as a racemate, is one of the most widely prescribed antidepressants. It has been shown that 
the different enantiomers display different pharmacological properties [5–7] and therefore the 
enantioselective synthesis of enantiopure compounds is of interest [8–12]. Several routes to produce 
optically pure 1,3-hydroxy esters have been explored, including asymmetric aldol reaction [13–16], the 
Reformatsky reaction [17–22], or regioselective epoxide ring opening [23–26]. The most widely studied 
method to achieve this kind of derivatives is asymmetric reduction, using either biocatalysts [4,27–30] or 
organometallic complexes [31–36] (Scheme 1). 
Scheme 1. Different asymmetric approaches to β-hydroxy esters. 
  
In comparison, kinetic resolution (KR) of β-hydroxy esters has been less studied. There are four 
different kinetic resolution approaches to prepare β-hydroxy esters including: hydrolytic KR [37–40], 
oxidative KR [41,42], acylation reactions [43–45], and dehydrative KR [46] (Scheme 2a–d). 
Scheme 2. Kinetic resolution alternatives of β-hydroxy esters: (a) hydrolytic KR; (b) 
oxidative KR, (c) acylative KR and (d) dehydrative KR. 
 
With the exception of oxidative KR, which takes place in the presence of a palladium complex 
containing (−)-sparteine ligand [41,42], and the dehydrative KR, in which a chiral aminoalcohol in the 
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presence of a zinc complex dehydrates the chiral alcohol [46], the remaining examples described in 
bibliography to date are enzymatic processes [37–40,43–45]. 
In the last decade, several organocatalysts for the enantioselective acylation of alcohols have been 
developed as an alternative to enzymes [47]. In 1996, Vedejs and Chen described the first example of a 
chiral DMAP derivative catalyst for the kinetic resolution of secondary aryl alcohols [48,49]. 
Independently, Fu and co-workers developed the synthesis of planar-chiral ferrocenyl DMAP 
analogues, e.g., (−)-1, which catalyzed the kinetic resolution of secondary aryl [50,51], allylic [52] and 
propargylic [53] alkyl alcohols with good selectivity factors. In addition, Fu and co-workers recently 
reported the compatibility of (−)-1 with a ruthenium-based racemization catalyst representing the first 
highly selective non-enzymatic dynamic kinetic resolution (DKR) of secondary alcohols [54,55]. 
The advantages of using the planar-chiral ferrocene DMAP derivative are that both (S)-(−)-1 and 
(R)-(+)-1 enantiomers are commercially available providing an easy access to both enantiomers of the 
substrates. Further, the kinetic resolution can be performed with low loading of the planar-chiral 
DMAP catalyst (1–2 mol %), the catalyst can easily be recovered after the reaction by simple flash 
chromatography [50,51], and it is possible to combine it with a racemization catalyst for an appealing 
DKR [54,55]. We have focused our effort in expanding the substrate scope of the KR by (−)-1 to sec-aryl 
alcohols that contains an additional heteroatom-containing functional group in the alkyl moiety [56,57] 
(Scheme 3), which includes aromatic β-azido alcohols and β-hydroxy phosphonate alcohols, that are 
important intermediates for the synthesis of bioactive molecules. 
Scheme 3. Kinetic resolution of secondary aryl alcohol catalyzed by planar-chiral DMAP 
derivative (−)-1. 
 
In this study, we wish to present the non-enzymatic kinetic resolution of a variety of β-hydroxy 
esters with good to excellent selectivities, using the planar-chiral ferrocenyl DMAP catalyst (−)-1. 
Furthermore, the utility of the present method could be demonstrated in the synthesis of the  
(S)-3-hydroxy-N-methyl-3-phenylpropanamide, which is a key intermediate for highly selective 
norepinephrine or serotonin reuptake inhibitor aryloxyphenylpropylamine derivatives, such as fluoxetine, 
tomoxetine or nisoxetine, in their enantiomerically pure forms. 
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2. Results and Discussion 
2.1. Substrate Screening 
In accordance with previous studies [51,56,57], the kinetic resolution of secondary alcohols 
catalyzed by the planar-chiral DMAP catalyst (−)-1 proceeds in an efficient and selective way in  
tert-amyl alcohol and in the presence of acetic anhydride (0.75 equiv.) as acylation agent. Employing 
these conditions, the influence of the temperature and addition of triethylamine was investigated in the 
kinetic resolution of rac-(2a), which was used as a model substrate in order to find the best conditions 
for the selectivity of the reaction. Using the standard conditions, it was found that the selectivity factor 
increases when the reaction was performed at lower temperature, but at the expense of the reaction rate 
with a subsequent increase of the reaction times. Previously, the addition of triethylamine increased the 
rate of the reaction [50–52]. Unfortunately, triethylamine catalyzed the unselective acetylation of the 
more reactive β-hydroxy esters, resulting in a decrease of the selectivity. For this reason, the rest of the 
kinetic resolution studies of the β-hydroxy esters were performed at a lower temperature (0 °C) and 
without addition of base. 
Next, we wanted to explore the influence of the bulkiness of the substituent in the β-position to the 
hydroxyl group on the selectivity of the kinetic resolution. Kinetic resolutions were performed for the 
substrates (2a–i) containing either ethyl or the bulkier tert-butyl carboxylate group using the standard 
conditions. The selectivity factor was determined from the enantiomeric excess of the chiral alcohol 
and the acetylated product after 3 h of reaction (Entries 1 to 9, Table 1). 
Table 1. Selectivity for the kinetic resolution of β-hydroxy-β-aryl esters (rac-2) by (−)-1 a. 
 
Entry R Ar Time/h eeROH (%) b eeROAc (%) b Conv. (%) c s c 
1 Et Ph (2a) 3 32.4 95.4 25.4 58 
2 Et 4-NO2-Ph (2b) 3 84.2 92.8 44.6 71 
3 Et 4-MeO-Ph (2c) 3 39.8 94.6 29.6 53 
4 tert-Bu Ph (2d) 3 28.8 95.2 23.2 54 
5 tert-Bu 4-NO2-Ph (2e) 3 88.4 93.6 48.6 89 
6 tert-Bu 4-MeO-Ph (2f) 3 39.4 96.0 29.1 72 
7 tert-Bu 2-Naphthyl (2g) 3 83.4  95.2 46.7 107
8 tert-Bu 4-Cl-Ph (2h) 3 75.0 95.2 44.1 92 
9 tert-Bu 2,6-Cl2-Ph (2i) 3 40.4 96.6 29.5 86 
a: Reaction conditions: rac-(2) (0.15 mmol), Ac2O (0.75 equiv.), (−)-1 (0.003 mmol, 2 mol %) in 0.6 mL of 
tert-amyl alcohol at 0 °C; b: Determined by HPLC; c: Selectivity and conversion calculated using the 
following equations: s = ln[(1 − c)(1 − eeROH)]/ln[(1 − c)(1 + eeROH)] and c = eeROH/(eeROH + eeROAc).  
In general, the substrates bearing the bulkier tert-butyl group show higher selectivity than the 
substrates with the ethyl substituents. The largest difference is seen for the substrates containing the 
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electron donating methoxy group or an electron-withdrawing nitro group in the para position (Entries 1–6, 
Table 1). The tendency that kinetic resolutions of substrates with more bulky alkyl substituents lead to 
higher selectivity is in agreement with the results previously reported by Fu for secondary benzylic 
alcohols with a bulky aliphatic substituent (the tert-butyl compared to the methyl substituent) [51] as 
well as for secondary β-hydroxyl-β-aryl phosphonates [57]. 
We also wanted to explore the influence of electronic effects of the substitution on the aromatic 
ring. The replacement of the phenyl group with an aryl containing an extended π-system led to a higher 
selectivity (selectivity factor of 107) and a faster reaction rate compared to the parent compound (entry 4 
vs. entry 7, Table 1). This is consistent with a suggested π–cation interaction between the cationic 
acylated catalyst and the aromatic substituent, which has previously been suggested for other catalytic 
systems [58–60]. In general, substrates with additional substituents gave a higher selectivity than the 
parent compound. For example, the compound with an electron donating methoxy group in the para 
position (2f) (entry 4 vs. entry 6, Table 1) and substrates with electron withdrawing groups in the 
phenyl ring led to higher selectivity compared to the parent compound. The results follow the previous 
trend [56,57] that electron-withdrawing substituents in the aromatic ring lead to a higher selectivity. 
This suggests that the electronic properties affect the interactions between the aromatic ring of the 
substrate and the acylated catalyst. 
The kinetic resolutions were also performed with longer reaction times (24 h) in order to be able to 
access the remaining alcohol in high enantiomeric excess (Table 2). We were able to isolate all the 
alcohols 2a–f in high enantiomeric excess (95%–99% ee) and in good to moderate yield (23%–45%). 
Table 2. Substrate screening for the kinetic resolution of β-hydroxy-β-aryl esters (rac-2) 
by (−)-1 a. 
 
Entry R Ar Conv. (%) c Yield (%) d eeROH (%) e 
1 Et Ph (2a) 57 41 99 
2 Et 4-NO2-Ph (2b) 79 23 99 f 
3 Et 4-MeO-Ph (2c) 55 32 99 f 
4 b tert-Bu Ph (2d) 56 39 95 
5 tert-Bu 4-NO2-Ph (2e) 66 33 99 f 
6 tert-Bu 4-MeO-Ph (2f) 55 41 99 
7 tert-Bu 2-Naphthyl (2g) 54 45 98 
8 tert-Bu 4-Cl-Ph (2h) 65 34 99 f 
9 b tert-Bu 2,6-Cl2-Ph (2i) 63 31 99 f 
a: Reaction conditions: rac-2 (0.25 mmol), Ac2O (0.75 equiv.), (−)-1 (0.005 mmol, 2 mol %) in 1 mL of  
tert-amyl alcohol at 0 °C, 24 h unless otherwise specified; b: 48 h; c: Conversion calculated using the 
following equation: c = eeROH/(eeROH + eeROAc); d: Isolated yield base on rac-2; e: Determined by HPLC;  
f: A single peak was judged as 99% ee. 
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2.2. Assignment of the Absolute Configuration of 2e and 2i after KR 
The absolute configuration of the optically pure β-hydroxy esters was assigned by comparing the 
sign of the optical rotation with literature values. Ethyl (S)-3-(4-nitrophenyl)-3-hydroxypropanoate  
(S)-2e and ethyl (S)-3-(2,6-dichlorophenyl)-3-hydroxypropanoate (S)-2i were the two substrates whose 
specific rotations are not reported in the literature and had to be determined. In order to confirm the 
absolute configuration of these two substrates after KR, the secondary alcohol was derivatized with a 
chiral auxiliary of already known absolute configuration (Scheme 4). 
Scheme 4. Synthesis of the Mosher’s esters using (R)-MTPA chloride as chiral derivatization agent. 
 
Numerous chiral derivatizing reagents have been described and used to assign the absolute 
configuration of chiral secondary alcohols [61]. The most common are the aryl-containing carboxylic 
acids (R)-(+) and (S)-(−)-α-methoxy-α-trifluoromethylphenylacetic acid (MTPA, Mosher’s reagent;  
(4) [62]. Chadha et al., reported the assignment of the absolute configuration of β-hydroxy esters using 
a single enantiomer of Mosher’s acid chloride [63–65]. 
Firstly, the Mosher’s ester of the racemic mixture and the (S)-enantiomer of the substrate tert-butyl 
3-hydroxy-3-(2-naphthyl)propanoate (2g) were prepared and used to validate the method. The 1H-NMR 
spectrum of the mixture of diastereomers formed shows that the chemical shift difference between the 
methoxy signals is significant enough to be used for the differentiation of the diastereomers  
(Figure 1a), as reported by Padhi and Chadha [64]. This chemical shift difference in the diastereomer 
originates from the fact that the methoxy group and the aromatic ring of the β-hydroxy ester are on the 
same side of the MTPA plane (i.e., (S)-2g-(R)-MTPA) and that the signal for the methoxy group 
protons is shielded due to the diamagnetic effect of the aromatic ring and appears at a lower chemical 
shift (3.42 ppm) (see Figure 1). The signal from the methoxy protons of the other diastereomer (i.e., 
(R)-2g-(R)-MTPA) appears downfield (3.56 ppm) because they are less shielded. In the same manner, 
the signals of the CF3 group allow the assignment by 19F-NMR and eliminate the possibility of 
overlapping signals (Figure 1b). The signal at −71.68 ppm belongs to the diastereomer that has the CF3 
group and the aromatic ring on the same side of the MTPA plane (i.e., (R)-2g-(R)-MTPA), whereas the 
signal at −71.31 ppm belongs to the other diastereomer that has these two groups in opposite sides of 
the plane (i.e., (S)-2g-(R)-MTPA) (see Figure 1). 
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Figure 1. (a) 1H-NMR of the methoxy region of (R)-MTPA esters of rac-2g (above) and 
(R)-MTPA ester of (S)-2g (below); (b) 19F-NMR of (R)-MTPA esters of rac-2g (above) 
and (R)-MTPA ester of (S)-2g (below).  
 
Therefore, the analysis of the 1H and 19F-NMR spectrum of the known enantiomer of (S)-2g allows 
us to conclude that obtained enantiomer has (S)-configuration which is in agreement with the 
previously reported sign of the optical rotation. The same method was used to determine the absolute 
configuration of the enantiomerically pure unknown enantiomers of 2e and 2i obtained after kinetic 
resolution. The 1H-NMR analysis of the Mosher’s esters (Figures 2a and 3b) shows that the signals of 
the methoxy protons are shielded (3.43 and 3.49 ppm for the Moshers esters of enantiopure 2e and 2i 
respectively). This supports the fact that the formed diastereomers have the methoxy group and the 
aromatic ring in the same side of the MTPA plane, i.e., the β-hydroxy esters have (S)-configuration. 
The same conclusion can be drawn from the 19F-NMR spectrum. The fluorine signal obtained 
belongs to the (S)-2e-(R)-MTPA (−71.29 ppm, Figure 2b) and (S)-2i-(R)-MTPA (−71.49 ppm, Figure 2b) 
because it appears in the deshielded region and this it indicates that the CF3 group and the aromatic 
ring are not in the same side of the plane as previously observed. 
The 1H-NMR and 19F-NMR analyses confirm that the absolute configuration of ethyl (S)-3-(4-
nitrophenyl)-3-hydroxypropanoate (S)-2e and ethyl (S)-3-(2,6-dichlorophenyl)-3-hydroxypropanoate 
(S)-2i is S. 
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Figure 2. (a) 1H-NMR of the methoxy region of (R)-MTPA esters of rac-2e (above) and 
(R)-MTPA ester of (S)-2e (below); (b) 19F-NMR of (R)-MTPA esters of rac-2e (above) 
and (R)-MTPA ester of (S)-2e (below). 
 
Figure 3. (a) 1H-NMR of the methoxy region of (R)-MTPA esters of rac-2i (above) and 
(R)-MTPA ester of (S)-2i (below); (b) 19F-NMR of (R)-MTPA esters of rac-2i (above) and 
(R)-MTPA ester of (S)-2i (below). 
 
2.3. Synthesis of (S)-3-Hydroxy-N-methyl-3-phenylpropanamide 
In order to demonstrate the synthetic applicability of the present method, the synthesis of the 
enantiomerically pure intermediate (S)-3-hydroxy-N-methyl-3-phenylpropanamide was carried out 
(Scheme 5). First, the kinetic resolution of ethyl 3-hydroxy-3-phenylpropanoate, rac-2a (547.6 mg,  
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2.8 mmol) was performed, recovering 62% of the (S)-enantiomer (32% yield, 99% ee). The subsequent 
treatment of the β-hydroxy esters with aqueous methylamine gave access to the β-hydroxy amide (S)-4 
in 85% yield and with retention of the configuration (99% ee). The β-hydroxyamide (S)-4 can then be 
reduced by lithium aluminium hydride in THF to the corresponding amine, followed by an aromatic 
nucleophilic substitution by 4-chlorobenzotrifluoride using sodium hydride in DMF, in order to yield 
(S)-fluoxetine [8–12]. 
Scheme 5. Synthesis of (S)-3-hydroxy-N-methyl-3-phenylpropanamide.  
 
Reagents and conditions: (i) rac-(2a) (2.8 mmol), Ac2O (0.75 equiv.), (−)-1 (0.005 mmol, 2 mol %) 
in 1 mL of tert-amyl alcohol at 0 °C, 24 h. (ii) MeNH2 (40% aq), r.t, 3 h. 
3. Experimental Section 
3.1. General Information 
Commercially available reagents were purchased from Sigma-Aldrich Co. and used without further 
purification. Thin layer chromatography (TLC) was performed on ALUGRAM® SIL G/UV254 plates 
(0.2 mm), using UV-light (254 nm) for visualization. Flash column chromatography was performed 
using Merck silica gel (0.04–0.06 mm). 1H and 13C{1H} NMR spectra were recorded on a Varian 
Mercury 300 MHz, Varian Unity 400 MHz or Varian Unity 500 MHz spectrometer. The chemical shift 
values (δ) are given in parts per million (ppm) and are referred to the residual peak of the deuterated 
solvent used (CDCl3). Chemical shifts and literature NMR shifts were used as references in 
identification and characterization of the optically pure synthesized compounds. Characterization data 
for these compounds are as follows (copies of the HPLC chromatograms, 1H- and 13C{1H}-NMR 
spectra are included in the Supplementary data). IR spectra were recorded on a PerkinElmer Spectrum 
One (ATR Technique). High-resolution mass spectra were recorded by Aleh Yahorau, Department of 
Pharmaceutical Biosciences, Uppsala University, Sweden. 
3.2. Preparation of the Racemic Substrates 
3.2.1. General Procedure 
The racemic substrates 2a–c and 4a–f were prepared following the procedure described by Xu and 
Yuan [43]. The racemic acetates 3a–c and 5a–f were prepared, as a references for the measurement of 
the HPLC retention times, by routine acetylation of the corresponding alcohols in dichloromethane at 
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r.t. in the presence of catalytic amounts of DMAP and triethylamine. Chemical shifts and literature 
NMR shifts were used as references in identification and characterization of the synthesized 
compounds [43,66–71]. For the new substrates (4b and 4f) the IR and HRMS data are included in the 
characterization data. 
3.2.2. Characterization Data 
Ethyl 3-hydroxy-3-phenylpropanoate (2a) [43] 
 
1H-NMR (CDCl3) δ 7.28–7.17 (m, 5H, Ar-H), 5.04 (dd, J = 7.8, 4.2 Hz, 1H, CH), 4.10 (m, J = 6.9 Hz, 2H, 
CH2), 3.22 (bs, 1H, OH), 2.64-2.50 (m, 2H, CH2), and 1.17 (t, J = 6.9 Hz, 3H, CH3). 13C{1H}-NMR 
(CDCl3) δ 172.6, 142.8, 128.8 (2C), 128.0, 125.9 (2C), 70.6, 61.1, 43.6 and 14.4. 
Ethyl 3-hydroxy-3-(4-nitrophenyl)propionate (2b) [43] 
 
1H-NMR (CDCl3) δ 7.87 (d, 2H, Ar-H), 7.46 (d, 2H, Ar-H), 5.25 (dd, J = 7.8, 4.2 Hz, 1H, CH), 4.29–4.11 
(m, 2H, CH2), 3.62 (bs, 1H, OH), 2.71 (q, J = 6.9 Hz, 2H, CH2) and 1.24 (t, J = 6.9 Hz, 3H, CH3). 
13C{1H}-NMR (CDCl3) δ 172.0, 149.9, 147.4, 126.2 (2C), 123.9 (2C), 69.2, 61.3, 43.1 and 14.1. 
Ethyl 3-hydroxy-3-(4-metoxyphenyl)propionate (2c) [66] 
 
1H-NMR (CDCl3) δ. 7.29 (d, 2H, J = 7.5 Hz, Ar-H), 6.86 (d, 2H, J = 7.5 Hz, Ar-H), 5.08 (dd, J = 8.8,  
4.0 Hz, 1H, CH), 4.19–4.09 (m, 2H, CH2), 3.80 (s, 3H, OCH3), 2.76–2.69 (m, 2H, CH2) and 1.27 (t,  
J = 6.9 Hz, 3H, CH3). 13C{1H}-NMR (CDCl3) δ 172.3, 159.1, 134.8, 126.9 (2C), 113.8 (2C), 69.9, 60.7, 
55.2, 43.3 and 14.1. 
t-Butyl 3-hydroxy-3-phenylpropionate (2d) [67] 
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1H-NMR (CDCl3) δ 7.39–7.22 (m, 5H, Ar–H), 5.07 (dd, 1H, J = 7.8, 4.2 Hz, CH), 3.42 (bs, 1H, OH), 
2.67 (dd, 1H, J = 16.0, 4.8 Hz, CH2), 2.61 (dd, 1H, J = 16.0, 4.8 Hz, CH2) and 1.43 (s, 9H, 3 CH3). 
13C{1H}-NMR (CDCl3) δ 171.9, 142.6, 128.4 (2C), 127.6, 125.7 (2C), 81.5, 70.4, 44.3 and 28.0. 
t-Butyl 3-hydroxy-3-(4-nitrophenyl)propionate (2e) [68] 
 
1H-NMR (CDCl3) δ 8.20 (d, 2H, J = 8.1 Hz, Ar-H), 7.55 (d, 2H, J = 8.1 Hz, Ar-H), 5.18 (dd, J = 8.3, 
4.1 Hz, 1H, CH), 2.73–2.57 (m, 2H, CH2) and 1.49 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.3, 
150.0, 147.3, 126.5 (2C), 123.6 (2C), 82.1, 69.4, 43.8 and 28.0. IR (neat): v(cm−1) 3438, 2941, 2977, 
2903, 1700, 1510, 1343, 1148, 843. HRMS (ESI, m/z) Calcd for C13H18NO5+ [M+H+]: 268.1185, 
found: 268.1189. 
t-Butyl 3-hydroxy-3-(4-methoxyphenyl)propionate (2f) [69] 
 
1H-NMR (CDCl3) δ 7.29 (d, 2H, J = 7.5 Hz, Ar-H), 6.86 (d, 2H, J = 7.5 Hz, Ar-H), 5.01 (dd, J = 8.8,  
4.0 Hz, 1H, CH), 3.78 (s, 3H, OCH3), 3.15 (bs, 1H, OH), 2.71–2.54 (m, 2H, CH2) and 1.44 (s, 9H, 3 
CH3). 13C{1H}-NMR (CDCl3) δ 171.9, 159.1, 134.9, 127.0 (2C), 113.8 (2C), 81.4, 70.0, 55.2, 44.3, 
and 28.0. 
t-Butyl 3-hydroxy-3-(2-naphthyl)propionate (2g) [70] 
 
1H-NMR (CDCl3) δ 7.85–7.81 (m, 4H, Ar-H), 7.50–7.26 (m, 3H, Ar-H), 5.26 (dd, J = 7.3, 5.5 Hz, 1H, 
CH), 2.76–2.74 (m, 2H, CH2) and 1.46 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.9, 140.1, 133.3, 
133.0, 128.3, 128.0, 127.7, 126.1, 125.9, 124.5, 123.9, 81.6, 70.5, 44.3 and 28.1. 
t-Butyl 3-hydroxy-3-(4-chloro)propionate (2h) [69] 
 
Molecules 2014, 19 14284 
 
 
1H-NMR (CDCl3) δ 7.34–7.31 (m, 4H, Ar-H), 5.09–5.05 (m, 1H, CH), 2.63–2.60 (m, 2H, CH2) and 
1.45 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.7, 141.1, 133.3, 128.6 (2C), 127.1 (2C), 81.7, 69.7, 
44.1 and 28.0. 
t-Butyl 3-hydroxy-3-(2',6'-dichlorophenyl) propionate (2i) 
 
1H-NMR (CDCl3) δ 7.32–7.12 (m, 3H, Ar-H), 5.90 (dd, 1H, J = 10.5, J = 4.2 Hz, 1H, CH), 3.23–2.62 
(m, 2H, CH2) and 1.46 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 170.5, 136.2, 134.6, 129.4 (2C), 
129.2 (2C), 81.3, 68.2, 40.7 and 28.0. IR (neat): v(cm−1) 3514, 2987, 2938, 1700, 1561, 1144, 766. 
HRMS (ESI, m/z) Calcd for C13H17Cl2O3+ [M+H+]: 291.0555, found: 291.0551. 
3.3. General Procedure for the Kinetic Resolution 
3.3.1. Selectivity Factor for the KR of 2a–i after 3 h 
Catalyst (−)-1 (2.0 mg, 0.003 mmol), β-hydroxy ester 2a–i (0.15 mmol) and t-amyl alcohol  
(0.6 mL) were sequentially added to a vial. The vial was capped and stirred at room temperature to 
help dissolve the catalyst. The reaction mixture was cooled to 0 °C in an ice-water bath and stirred for 
15 min. Then, acetic anhydride (11 μL, 0.11 mmol) was added. After 3 h, a sample (0.2–0.3 mL) was 
quenched by the addition of methanol. The resulting solution was filtered through a short plug of silica 
using ether as eluent and then it was concentrated. The enantiomeric excess of the unreactive alcohol 
and the acetate were determined by HPLC (Table 1) using the appropriate chiral column and 
conditions. The chromatograms are attached in Supplementary section 1. 
The selectivity s was calculated using the Equation (1), where C is the conversion (calculated using 
the Equation (2), eeROH and eeROAc are the enantiomeric excess for the unreactive alcohol and the 
resulting acetate respectively determined by HPLC [47]: 
S =
ln[(1 − C)(1 − eeROH)]
ln[(1 − C)(1 + eeROH)] =
ln[1 − C(1 + eeROAc)]
ln[1 − C(1 − eeROAc)] (1)
C =
 eeROH
 eeROH + eeROAc
 (2)
3.3.2. Synthesis of Optically Pure Alcohols 
Catalyst (−)-1 (3.3 mg, 0.005 mmol), β-hydroxy ester 2a–i (0.25 mmol) and t-amyl alcohol (1.0 mL) 
were sequentially added to a vial. The vial was capped and stirred at room temperature to help dissolve 
the catalyst. The reaction mixture was cooled to 0 °C, and then acetic anhydride (18 μL, 0.19 mmol) 
was added. After the appropriate amount of time, the reaction mixture was quenched by the addition of 
a large excess of methanol. The resulting solution was concentrated, and the unreactive alcohol, the 
acetate and the catalyst were separated by flash chromatography using increasing polarity mixtures of 
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pentane/ethyl acetate as eluent. The enantiomeric excess of the unreactive alcohol and the acetate were 
determined by HPLC (Table 2). The chromatograms are attached in Supplementary section 2. 
Chemical shifts and literature NMR shifts were used as references in identification and 
characterization of the optically pure synthesized compounds 2a–i. The 1H and 13C{1H}-NMR spectra 
are attached in Supplementary section 3. 
Ethyl (S)-3-hydroxy-3-phenylpropanoate ((S)-2a) [43]. Colorless oil (21.8 mg, 41% yield); ee 95%, 
Kromasil 5-CellCoat, n-hexane/i-PrOH = 95:05, 0.5 mL/min, 220 nm, tR[(S)/(R)] = 20.5/28.5 min;  
[α]25 D : −45.3 (c 3.7, CDCl3) (Lit. [71] [[α]25 D : = −46.5 (c 1.04, CHCl3)). 1H-NMR (CDCl3) δ 7.28–7.17 
(m, 5H, ArH), 5.04 (dd, J = 7.8, 4.2 Hz, 1H, CH), 4.10 (m, J = 6.9 Hz, 2H, CH2), 3.22 (bs, 1H, OH), 
2.64–2.50 (m, 2H, CH2), and 1.17 (t, J = 6.9 Hz, 3H, CH3). 13C{1H}-NMR (CDCl3) δ 172.6, 142.8, 
128.8 (2C), 128.0, 125.9 (2C), 70.6, 61.1, 43.6 and 14.4. 
Ethyl (S)-3-hydroxy-3-(4-nitrophenyl)propanoate ((S)-2b) [43]. Colorless oil (13.8 mg, 23% yield);  
ee 99%, Chiralpack AD, n-hexane/i-PrOH = 90:10, 0.5 mL/min, 220 nm, tR[(S)/(R)] = 26.6/28.4 min. 
[α]20 D : −58.0 (c 0.23, CHCl3) (Lit. [64] [α]25 D : −59.5 (c 1.5, CHCl3)). 1H-NMR (CDCl3) δ 7.87 (d, 2H, 
ArH), 7.46 (d, 2H, ArH), 5.25 (dd, J = 7.8, 4.2 Hz, 1H, CH), 4.29–4.11 (m, 2H, CH2), 3.62 (bs, 1H, 
OH), 2.71 (q, J = 6.9 Hz, 2H, CH2) and 1.24 (t, J = 6.9 Hz, 3H, CH3). 13C{1H}-NMR (CDCl3)  
δ 172.0, 149.9, 147.4, 126.2 (2C), 123.9 (2C), 69.2, 61.3, 43.1 and 14.1. 
Ethyl (S)-3-hydroxy-3-(4-methoxyphenyl)propanoate ((S)-2c) [66]. Yellow oil (18.0 mg, 32% yield); 
ee 99%, Reprosil chiral NR, n-hexane/i-PrOH = 80:20, 0.5 mL/min, 220 nm, tR[(S)/(R)] = 15.9/18.7 min. 
[α]20 D : −45.9 (c 0.75, CHCl3) (Lit. [71] [α]26 D : −28.6 (c 1, CHCl3)). 1H-NMR (CDCl3) δ 7.29 (d, 2H,  
J = 7.5 Hz, ArH), 6.86 (d, 2H, J = 7.5 Hz, ArH), 5.08 (dd, J = 8.8, 4.0 Hz, 1H, CH), 4.19–4.09 (m, 2H, 
CH2), 3.80 (s, 3H, OCH3), 2.76–2.69 (m, 2H, CH2) and 1.27 (t, J = 6.9 Hz, 3H, CH3). 13C{1H}-NMR 
(CDCl3) δ 172.3, 159.1, 134.8, 126.9 (2C), 113.8 (2C), 69.9, 60.7, 55.2, 43.3 and 14.1. 
tert-Butyl (S)-3-hydroxy-3-phenylpropanoate ((S)-2d) [67]. Pale yellow oil (21.6 mg, 39% yield); ee 
95%, Reprosil Chiral NR, n-hexane/i-PrOH = 99:01, 1.0 mL/min, 220 nm, tR[(S)/(R)] = 11.4/15.6 min. 
[α]20 D : −85.0 (c 0.1, CHCl3) (Lit. [71] [α]25 D : −37.7 (c 1.2, CHCl3)). 1H-NMR (CDCl3) δ 7.39–7.22 (m, 
5H, ArH), 5.07 (dd, 1H, J = 7.8, 4.2 Hz, CH), 3.42 (bs, 1H, OH), 2.67 (dd, 1H, J = 16.0, 4.8 Hz, CH2), 
2.61 (dd, 1H, J = 16.0, 4.8 Hz, CH2) and 1.43 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.9, 142.6, 
128.4 (2C), 127.6, 125.7 (2C), 81.5, 70.4, 44.3 and 28.0. 
tert-Butyl (S)-3-hydroxy-3-(4-nitrophenyl)propanoate ((S)-2e) [68]. Yellow oil (18.0 mg, 32% yield); 
ee 99%, Reprosil Chiral NR, n-hexane/i-PrOH = 90:10, 0.5 mL/min, 220 nm, tR[(S)/(R)] = 14.5/15.5 min. 
[α]20 D : −31.4 (c 0.19, CHCl3). 1H-NMR (CDCl3) δ 8.20 (d, 2H, J = 8.1 Hz, ArH), 7.55 (d, 2H,  
J = 8.1 Hz, ArH), 5.18 (dd, J = 8.3, 4.1 Hz, 1H, CH), 2.73–2.57 (m, 2H, CH2) and 1.49 (s, 9H, 3 CH3). 
13C{1H}-NMR (CDCl3) δ 171.3, 150.0, 147.3, 126.5 (2C), 123.6 (2C), 82.1, 69.4, 43.8 and 28.0. IR 
(neat): v(cm−1) 3438, 2941, 2977, 2903, 1700, 1510, 1343, 1148, 843. HRMS (ESI, m/z) Calcd for 
C13H18NO5+ [M+H+]: 268.1185, found: 268.1189. 
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tert-Butyl (S)-3-hydroxy-3-(4-methoxyphenyl)propanoate ((S)-2f) [69]. Yellow oil (26.0 mg, 41% 
yield); ee 99% after acetylation with DMAP, Chiralpak AD, n-hexane/i-PrOH = 90:10, 0.5 mL/min, 
220 nm, tR[(S)/(R)] = 24.8/11.9 min. [α]20 D : −34.5 (c 1.6, CHCl3) (Lit. value for the (R)-enantiomer [46]  
[α]20 D : +28.0 (c 0.15, CHCl3)). 1H-NMR (CDCl3) δ 7.29 (d, 2H, J = 7.5 Hz, ArH), 6.86 (d, 2H, J = 7.5 Hz, 
ArH), 5.01 (dd, J = 8.8, 4.0 Hz, 1H, CH), 3.78 (s, 3H, OCH3), 3.15 (bs, 1H, OH), 2.71–2.54 (m, 2H, 
CH2) and 1.44 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.9, 159.1, 134.9, 127.0 (2C), 113.8 (2C), 
81.4, 70.0, 55.2, 44.3, and 28.0. 
tert-Butyl (S)-3-hydroxy-3-(2-naphthyl)propanoate ((S)-2g) [70]. Yellow oil (30.3 mg, 45% yield); ee 
96%, Kromasil 5-CellCoat, n-hexane/i-PrOH = 99:01, 1.0 mL/min, 220 nm, tR[(S)/(R)] = 26.4/29.6 min. 
[α]20 D : −36.9 (c 0.42, CHCl3) (Lit. [21] [α]20 D : −24.8 (c 1.1, CHCl3)). 1H-NMR (CDCl3) δ 7.85–7.81 (m, 
4H, ArH), 7.50–7.26 (m, 3H, ArH), 5.26 (dd, J = 7.3, 5.5 Hz, 1H, CH), 2.76–2.74 (m, 2H, CH2) and 
1.46 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 171.9, 140.1, 133.3, 133.0, 128.3, 128.0, 127.7, 126.1, 
125.9, 124.5, 123.9, 81.6, 70.5, 44.3 and 28.1. 
tert-Butyl (S)-3-(4-chlorophenyl) 3-hydroxypropanoate ((S)-2h) [69]. Colorless oil (22.0 mg,  
33% yield); ee 99%, Reprosil Chiral NR, n-hexane/i-PrOH = 90:10, 0.5 mL/min, 220 nm, tR[(S)/(R)] = 
10.7/12.2 min. [α]20 D : −34.1 (c 1.9, CHCl3) (Lit. [21] [α]23 D : −25.4 (c 2.0, CHCl3)). 1H-NMR (CDCl3)  
δ 7.34–7.31 (m, 4H, ArH), 5.09–5.05 (m, 1H, CH), 2.63–2.60 (m, 2H, CH2) and 1.45 (s, 9H, 3 CH3). 
13C{1H}-NMR (CDCl3) δ 171.7, 141.1, 133.3, 128.6 (2C), 127.1 (2C), 81.7, 69.7, 44.1 and 28.0. 
tert-Butyl (S)-3-(2,6-dichlorophenyl) 3-hydroxypropanoate ((S)-2i). Colorless oil (23.0 mg, 31% yield); ee 
99%, Kromasil 5-CellCoat, n-hexane/i-PrOH = 99.5:0.5, 1.0 mL/min, 220 nm, tR[(S)/(R)] = 10.7/16.1 min. 
[α]20 D : +21.8 (c 2.0, CHCl3). 1H-NMR (CDCl3) δ 7.32–7.12 (m, 3H, ArH), 5.90 (dd, 1H, J = 10.5,  
J = 4.2 Hz, 1H, CH), 3.23–2.62 (m, 2H, CH2) and 1.46 (s, 9H, 3 CH3). 13C{1H}-NMR (CDCl3) δ 170.5, 
136.2, 134.6, 129.4 (2C), 129.2 (2C), 81.3, 68.2, 40.7 and 28.0. IR (neat): v(cm−1) 3514, 2987, 2938, 
1700, 1561, 1144, 766. HRMS (ESI, m/z) Calcd for C13H17Cl2O3+ [M+H+]: 291.0555, found: 291.0551. 
3.3.3. Methods Used to Determine Enantiomeric Excess 
The enantiomeric separations of β-hydroxy esters 2a–i were performed by high performance liquid 
chromatography (HPLC) with a Young Lin 9100 instrument using the appropriate chiral column at 25 °C 
with n-hexane and isopropanol as eluents. The enantiomeric separation of 2f was achieved converting 
the alcohol to the corresponding acetate using DMAP and triethylamine in DCM. The selectivity  
(S)-factors were calculated with the equation: S = ln[(1 − c)(1 − eeROH)]/ln[(1 − c)(1 + eeROH)]. 
3.4. Synthesis of (S)-3-Hydroxy-N-methyl-3-phenylpropanamide ((S)-4) 
Catalyst (−)-1 (37 mg, 0.0056 mmol), racemic substrate 2a (2.8 mmol) and tert-amyl alcohol (11 mL) 
were sequentially added to a vial. The vial was capped and stirred at room temperature to help dissolve 
the catalyst. The reaction mixture was cooled to 0 °C, and then acetic anhydride (200 μL, 2.1 mmol) 
was added. After 24 h, the reaction mixture was quenched by the addition of a large excess of 
methanol. The resulting solution was concentrated, and the unreactive alcohol was separated from the 
acetate and the catalyst by flash chromatography using increasing polarity mixtures of pentane/ethyl 
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acetate as eluent (175 mg, 32% yield, 99% ee). The β-hydroxy ester (S)-2a was treated with a 40% 
aqueous solution of methylamine (1.56 mL, 18 mmol) at r.t. during 3 h. Beige solid was obtained 
(137.8 mg, 85.3% yield, 99% ee). Chemical shifts and literature NMR shifts were used as references in 
identification and characterization of the optically pure synthesized compound (S)-4 [36]. Beige solid 
(138 mg, 85% yield); ee 99%, Chiralpak AD, n-hexane/i-PrOH = 98:02, 1.0 mL/min, 220 nm, 
tR[(R)/(S)] = 41/51 min. [α]20 D : −26.7 (c 1.0, CH3OH) (Lit. [36] [α]23 D : −26.2 (c 1.25, CH3OH)).  
1H-NMR (CDCl3) δ 7.49–7.14 (m, 5H, ArH), 5.82 (br s, 1H, NH), 5.16-5.05 (m, 1H, CHOH), 2.82 (d, 
J = 4.5 Hz, 3H, NHCH3), 2.59–2.52 (m, 2H, CH2). 13C{1H}-NMR (CDCl3) δ 172.56, 143.16, 128.67, 
127.84, 125.71, 71.07, 44.72, 26.37. 
4. Conclusions 
In summary, we have demonstrated that the planar-chiral DMAP derivative catalyst (−)-1 catalyzes 
the kinetic resolution for a range of aromatic β-hydroxy esters with excellent selectivities (selectivity 
factor up to 107) and high enantiomeric excess (up to 99% ee) of the remaining alcohol. To the best of 
our knowledge, these results represent the first example of the kinetic resolution of this family of 
substrates employing a chiral DMAP derivative as catalyst. 
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